Protective Efficacy of a Human Endogenous Retrovirus Envelope-Coated, Nonreplicable, Baculovirus-Based Hemagglutin Vaccine against Pandemic Influenza H1N1 2009

Despite the advantages of DNA vaccines, overcoming their lower efficacy relative to that of conventional vaccines remains a challenge. Here, we constructed a human endogenous retrovirus (HERV) envelope-coated, nonreplicable, baculovirus-based HA vaccine against swine influenza A/California/04/2009(H...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jae-Yoo, Gwon, Yong-Dae, Kim, Jeong-Ki, Cho, Yeon-Dong, Heo, Yoon-Ki, Cho, Han-Sam, Choi, Tae-Jin, Poo, Ha-Ryoung, Oh, Yu-Kyoung, Kim, Young Bong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832454/
https://www.ncbi.nlm.nih.gov/pubmed/24260476
http://dx.doi.org/10.1371/journal.pone.0080762

Ejemplares similares

Ejemplares similares